BANK OF MONTREAL /CAN/

Bank

Position in DMAC — DiaMedica Therapeutics Inc.

CIK 927971 TORONTO, A6

Position in DMAC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$386,805

+$260,647 QoQ

Shares Held

54,944

+194.8% QoQ

Ownership

0.102%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#26

of 87 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BANK OF MONTREAL /CAN/ holds $701,516,965 across 82 Biotechnology names. DMAC ranks #46 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	427,448	$212,326,240
2	HALO	Halozyme Therapeutics, Inc.	942,432	$73,764,150
3	ARGX	Argenx SE	77,213	$71,635,902
4	REGN	Regeneron Pharmaceuticals, Inc.	103,247	$64,378,631
5	JAZZ	Jazz Pharmaceuticals plc	242,063	$58,329,919
6	TGTX	Tg Therapeutics, Inc.	515,981	$28,347,995
7	MRNA	Moderna, Inc.	389,789	$27,296,921
8	CYTK	Cytokinetics Inc	285,688	$24,337,759

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$386,805	54,944	+194.8%	Shares	Defined	2026-08-12
2026-03-31	$126,158	18,635	+19.8%	Shares	Defined	2026-05-13
2025-12-31	$123,857	15,560	0.0%	Shares	Defined	2026-02-12
2025-09-30	$106,897	15,560	0.0%	Shares	Defined	2025-11-13
2025-06-30	$60,684	15,560	0.0%	Shares	Defined	2025-08-05
2025-03-31	$58,972	15,560	0.0%	Shares	Defined	2025-05-13
2024-12-31	$84,490	15,560	-89.1%	Shares	Defined	2025-02-13
2021-06-30	$635,663	142,846	+36.7%	Shares	Defined	2021-08-12
2021-03-31	$956,393	104,524	+27.7%	Shares	Defined	2021-05-13
2020-12-31	$830,283	81,882	+26313.5%	Shares	Defined	2021-02-12
2020-09-30	$1,314	310	0.0%	Shares	Defined	2020-11-12
2020-06-30	$2,148	310	0.0%	Shares	Defined	2020-08-12
2020-03-31	$868	310	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.